Reference
Lee JS, et al. Hepatic safety of febuxostat compared with allopurinol in gout patients with fatty liver disease. The Journal of Rheumatology 46: 527-531, No. 5, May 2019. Available from: URL: http://doi.org/10.3899/jrheum.180761 - SouthKorea
Rights and permissions
About this article
Cite this article
Allopurinol. Reactions Weekly 1758, 20 (2019). https://doi.org/10.1007/s40278-019-63566-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-63566-4